Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPTN 084 at the Kisumu, Kenya Clinical Research Site
PACTR202003492130332Phase 3Not yet recruiting
- Sponsor
- NIAID Division of AIDS
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cabotegravir, tenofovir disoproxil fumarate and emtricitabine in human immunodeficiency virus infection (HIV), sponsored by NIAID Division of AIDS. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
cabotegravirtenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202003492130332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202003492130332.